AzTrials
AzTrials

Diaper RashPhase 4NCT05892081

Colloidal Oatmeal, Colloid Cream, Diaper Rash, Preterm Neonates and Neonatal Intensive Care Unit

A Phase 4 study testing Colloidal oatmeal and Cold cream in people with Diaper Rash and Preterm Neonates, run by Seham El-Sayed Saleh Hassan at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

-This study aimed to investigate the effect of colloid oatmeal compared to colloid cream on diaper rash among preterm neonates in the NICU. Read more about this study

Who is it for?
Ages 34 to 37 weeks
Conditions the study is for
Diaper Rash, Preterm Neonates
What is being tested?
Colloidal oatmeal and Cold cream
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteEgypt
Study dates
20 Aug 2021to 30 Aug 2023
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 34 to 37 weeks
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Preterm neonates
  • Have diaper rash,
  • Hemodynamically stable
  • Receive enteral feeding (breast, bottle, gavage, or mixed feeding)
  • Newly admitted to the previously mentioned setting
  • On the first day of exposure to diaper rash

Who cannot join

  • Preterm who have candida infection in groin
  • Use other drugs for diaper rash

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Matrouh university

    Marsá Maţrūḩ

Other trials in Egypt

About this study

Official title: Effect of Colloidal Oatmeal Compared to Colloid Cream on Diaper Rash Among Preterm Neonates in the Neonatal Intensive Care Unit.

-This study aimed to investigate the effect of colloid oatmeal compared to colloid cream on diaper rash among preterm neonates in the NICU.

Read the detailed description

A quasi-experimental study was carried out in the NICU of El-Raml Children's Hospital at Wengat in Alexandria. Ninety preterm neonates were randomly assigned to three equal groups. The control group received the usual care of NICU for diaper rash, colloidal oatmeal group received colloidal oatmeal cream and colloid group received colloid cream (cold which is the base for colloid oatmeal)

Being tested
Colloidal oatmeal, Cold cream
Keywords
Colloidal oatmeal, Diaper rash, Preterm neonates
Medical subject headings
Diaper Rash

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Colloidal oatmealBiological

    The colloid oatmeal had the following component: Colloidal Oat (5gm), stearic acid 5, cretoctryl alcohol 2.5, cetyl alcohol 2.5, koh 02, potassium sorbate 1gm, paraffin oil 5ml, and soft paraffin 10gm

  • Cold creamBiological

    It is composed of stearic acid 5, cretoctryl alcohol 2.5, cetyl alcohol 2.5, koh 02, potassium sorbate 1gm, paraffin oil 5ml, and soft paraffin 10gm

Study groups in NCT05892081
Study groupRoleWhat they receive
Control groupNo interventionThe control group received the usual care of the unit.
Colloid groupExperimentalReceived cold cream three times a day on the rash area while diaper changing by the researcher plus the usual care
Receives: Biological: Cold cream
Colloid oatmeal groupExperimentalReceived colloid oatmeal cream three times a day on the rash area while diaper changing by the researcher plus the usual care
Receives: Biological: Colloidal oatmeal

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Preterm neonates who receive colloid assessed by rash scale score.

    Mild degree of diaper rash score will mean improvement in diaper rash

    Measured: four days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jun 2023
  2. Study start20 Aug 2021
  3. Primary completion12 Jan 2022
  4. Study completion30 Aug 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
90 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05892081
Sponsor's protocol ID
Document attached-Not given
Status last verified
Sep 2023
First submitted
11 Apr 2023
Last updated
22 Sep 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • American Academy of Pediatrics. (2014). Diaper rash. Available from: http//www.pdf secret.com _diaper-rash-southwest-childrens-center.pdf.

  • Altmann T, Fischman. (2018). The dreaded diaper rash: A pediatrician's advice for preventing and treating an angry bottom. The dreaded diaper rash: A pediatrician's advice for preventing and treating an angry bottom - The Washington Post.

  • Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN). Neonatal skin care evidence-based clinical practice guideline (3rd ed.). Washington, DC; (2013).

  • Baudouin C, Lachmann N, Rocheteau J, Chadoutaud B, Boy E, Leclere-Bienfait S. Diaper dermatitis management: a global and innovative strategy for a new generation of skin care. J Am Acad Dermatol, 2015; 72(5):199.

  • Blume-Peytavi U, Lavender T, Jenerowicz D, Ryumina I, Stalder JF, Torrelo A, Cork MJ. Recommendations from a European Roundtable Meeting on Best Practice Healthy Infant Skin Care. Pediatr Dermatol. 2016 May;33(3):311-21. doi: 10.1111/pde.12819. Epub 2016 Feb 26.

    PubMed 26919683
  • Blume-Peytavi U, Hauser M, Lunnemann L, Stamatas GN, Kottner J, Garcia Bartels N. Prevention of diaper dermatitis in infants--a literature review. Pediatr Dermatol. 2014 Jul-Aug;31(4):413-29. doi: 10.1111/pde.12348. Epub 2014 May 29.

    PubMed 24890321
  • Boyles, M. (2022).Health Benefits of Oatmeal and Oats. Available from: http//.www.Health Benefits of Oatmeal & Oats | Oatmeal to Soothe Itchy Skin | The Old Farmer's Almanac.

  • Buckley BS, Mantaring JB, Dofitas RB, Lapitan MC, Monteagudo A. A New Scale for Assessing the Severity of Uncomplicated Diaper Dermatitis in Infants: Development and Validation. Pediatr Dermatol. 2016 Nov;33(6):632-639. doi: 10.1111/pde.12988. Epub 2016 Sep 22.

    PubMed 27653955
  • Burdall O, Willgress L, Goad N. Neonatal skin care: Developments in care to maintain neonatal barrier function and prevention of diaper dermatitis. Pediatr Dermatol. 2019 Jan;36(1):31-35. doi: 10.1111/pde.13714. Epub 2018 Dec 2.

    PubMed 30506880
  • Chat, S., Uppal, S., Kearns, D., Ashin, J. Colloidal Oatmeal in the Treatment of Atopic Dermatitis Is this plant-based intervention an effective treatment alternative? By Practical Dermatology. 2020.

  • Collier M, Simon D. Protecting vulnerable skin from moisture-associated skin damage. Br J Nurs. 2016 Nov 10;25(20 Suppl):S26-S32. doi: 10.12968/bjon.2016.25.20.S26.

    PubMed 27834525
  • Furber C, Bedwell C, Campbell M, Cork M, Jones C, Rowland L, Lavender T. The challenges and realties of diaper area cleansing for parents. J Obstet Gynecol Neonatal Nurs. 2012 Nov-Dec;41(6):E13-25. doi: 10.1111/j.1552-6909.2012.01390.x. Epub 2012 Jul 23.

    PubMed 22822929
  • Gregorio J, and Rodriguez K. Diaper Dermatitis in Infant Skin: Causes and Mitigation. neonatal INTENSIVE CARE. 2017; 30 (3):38-40.

  • Hugill K. Revisiting infant nappy dermatitis: causes and preventive care. Br J Midwifery, 2017;25(3):150-54.

  • Ilnytska O, Kaur S, Chon S, Reynertson KA, Nebus J, Garay M, Mahmood K, Southall MD. Colloidal Oatmeal <em>(Avena Sativa)</em> Improves Skin Barrier Through Multi-Therapy Activity. J Drugs Dermatol. 2016 Jun 1;15(6):684-90.

    PubMed 27272074

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Colloidal oatmeal and Cold cream in people with Diaper Rash and Preterm Neonates, run by Seham El-Sayed Saleh Hassan at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Preterm neonates who receive colloid assessed by rash scale score. (time frame: four days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05892081, which also lists 24 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Sep 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in